1/87
Looks like no tags are added yet.
Most commonly used illicit drug in the US
Marijuana
Controlled Substances Act
1970 law that established five schedules for classifying controlled substances
Drug Enforcement Administration (DEA)
Agency established in 1973 to enforce controlled substance laws
Why substance-related disorders are grouped together
All 10 drug classes can activate the brain's neural reward circuitry
Gateway theory
The idea that people may progress from legal substances to marijuana and some may then try other illicit drugs
Phases of drug use
Recreational or nonproblematic use → regular use → problematic or addictive use → compulsive use and relapse
Maturing out
When some individuals naturally reduce or stop drug use as they get older
Addiction potential and onset
Faster onset and shorter time between taking a drug and feeling its effects generally increase addiction potential
Progressive-ratio procedure
A self-administration procedure that measures how much work an animal will do to obtain a drug
Breakpoint
The point at which an animal stops responding for a drug; a higher breakpoint indicates stronger reinforcement
Genetics and substance abuse
Genetics account for approximately 40–60% of the vulnerability to substance abuse
Self-medication hypothesis
The idea that people may use drugs to manage emotional symptoms
Self-medication example
Someone with anxiety may prefer sedatives while someone experiencing depression may seek stimulants
Biopsychosocial model
Addiction is influenced by biological, psychological, and social factors
Hyperkatifeia
A negative emotional state associated with drug withdrawal
Hyperkatifeia and escalating drug use
Negative emotions and withdrawal-related distress can become stronger as addiction develops
Mesolimbic dopamine and reward
Dopamine is essential for the rewarding effects of psychostimulants
Drug liking
How pleasurable or enjoyable a drug feels
Drug wanting
Motivation or desire to obtain and use a drug
Liking and wanting over time
Liking may decrease due to tolerance while wanting can increase through incentive sensitization
Negative reinforcement
Using a drug to remove or avoid unpleasant feelings or withdrawal symptoms
Drugs of abuse and brain stimulation threshold
Most drugs lower the threshold for brain stimulation responding
Withdrawal and brain stimulation threshold
Withdrawal increases the threshold
Three-stage addiction cycle
Binge/intoxication → withdrawal/negative affect → preoccupation/anticipation
Factor perpetuating addiction
Withdrawal and negative affect encourage continued drug use because the drug relieves unpleasant feelings
Voices of Hope approach
Harm reduction: meeting people where they are
Three-factor vulnerability model
Biological or genetic factors; psychological factors; sociocultural factors
Disulfiram mechanism
Inhibits aldehyde dehydrogenase (ALDH)
Disulfiram reaction
Acetaldehyde buildup causes flushing
Nonspecific effects of alcohol
Increases membrane lipid fluidity and changes relationships between membrane proteins
Naltrexone behavioral effect
Reduces the pleasurable high from alcohol by blocking opioid receptors and alcohol-induced endorphin effects
Naltrexone mechanism
Opioid receptor antagonist that reduces alcohol's rewarding effects
Asian Flush
Reaction caused by an inactive ALDH variant that leads to acetaldehyde buildup after drinking
Asian Flush symptoms
Flushing
Glutamate during alcohol withdrawal
Glutamate activity and release increase
Behavioral result of increased glutamate during withdrawal
Seizures can occur due to CNS hyperexcitability
Behavioral tolerance
Learning to compensate for a drug's effects while under its influence
Behavioral tolerance example
A person who has been drinking adjusts their movements to appear less impaired
Chronic alcohol and NMDA receptors
Repeated alcohol use upregulates NMDA glutamate receptors
Repeated alcohol exposure reduces
GABA-A-mediated chloride flow
Alcohol detox medication
Benzodiazepines such as chlordiazepoxide (Librium) or diazepam (Valium)
Acute alcohol and dopamine
Alcohol activates VTA dopamine neurons
Alcohol reward pathway
VTA → nucleus accumbens (NAcc); dopamine release contributes to positive reinforcement
Alcohol absorption
Alcohol is mainly absorbed through the small intestine by passive diffusion
Food and alcohol absorption
Food slows absorption by delaying movement from the stomach into the small intestine
Alcohol concentration and absorption
Higher alcohol concentration can lead to faster absorption
Sex differences in alcohol absorption
Women may absorb alcohol faster due to less gastric alcohol dehydrogenase and smaller body size
Acute tolerance
Tolerance that develops during one drinking episode
Acute tolerance and BAC
Alcohol effects are stronger while BAC is rising and weaker while BAC is falling
Risk of acute tolerance
Someone may feel less intoxicated while still being impaired
Alcohol and CNS
Alcohol is a CNS depressant
Alcohol effects on the CNS
Relaxation
Acute alcohol and glutamate
Acute alcohol reduces glutamate release and decreases the effects of NMDA receptors
Psychological risk factors for AUD
Stress
Crack cocaine route
Smoking; crack can be smoked unlike cocaine hydrochloride
Cocaine hydrochloride
Water-soluble form of cocaine that cannot be smoked
Cocaine and alcohol metabolite
Cocaethylene
Fastest cocaine routes
Smoking and IV injection deliver cocaine to the brain rapidly
Cocaine mechanism of action
Blocks reuptake of dopamine
Most important neurotransmitter for cocaine addiction potential
Dopamine; blocking dopamine reuptake is especially important for behavioral effects and addictive potential
Cocaine symptoms
Mimic the sympathetic nervous system or fight-or-flight response
Cocaine physiological effects
Increased heart rate
Cocaine reward pathway
Dopaminergic projections from the VTA and substantia nigra to the striatum and nucleus accumbens
Nucleus accumbens dopamine
Implicated in cocaine reward and drug-seeking behavior
Deep brain stimulation (DBS)
changes activity in brain circuits, most invasive, surgically implanted electrodes regulate abnormal activity
Methylphenidate (Ritalin)
Psychostimulant primarily used to treat ADHD
Methylphenidate mechanism
Blocks dopamine and norepinephrine transporters (DAT and NET)
Amphetamines
Synthetic psychostimulants structurally related to dopamine
Amphetamine mechanism
Indirect catecholamine agonists that stimulate dopamine and norepinephrine release and block reuptake
Amphetamine entry into neurons
Enters nerve terminals through DAT
Amphetamine dopamine release
Stimulates dopamine release from vesicles and reverses DAT to release dopamine into the synapse
Cocaine sensitization and tolerance
Depend on the pattern of exposure
Cocaine tolerance
Chronic exposure can downregulate dopaminergic activity and lead to tolerance
Cocaine sensitization
Intermittent exposure with repeated spikes can produce an increased response
Amphetamines and cathinones structural similarity
Amphetamines are structurally related to dopamine
Psychostimulants and PFC function
Increase dopamine and norepinephrine activity in the prefrontal cortex
Methylphenidate and PFC
Blocks DAT and NET to increase dopamine and norepinephrine in the PFC
Cocaine and PFC
Norepinephrine uptake inhibition can stimulate alpha-1 receptor activity and glutamatergic pyramidal neurons projecting to the VTA
Mephedrone and methylone
Synthetic cathinones with actions similar to amphetamine
Mephedrone and methylone mechanism
Act as substrates for DAT
MDPV and alpha-PVP
Synthetic cathinones that selectively inhibit dopamine and norepinephrine reuptake
Cocaine form with higher addiction potential
Crack or smoked cocaine because it reaches the brain rapidly
Individual differences in psychostimulant sensitivity
May be due to differences in baseline dopamine or dopamine transporter levels
Amphetamine neurobehavioral effects
Increased alertness
Amphetamines and sleep
Reduce sleep time
Amphetamines and physical effort
Allow sustained physical effort without rest or sleep